Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter P Du

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancer Discovery|January 28, 2025
Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in MelanomaSapir Cohen Shvefel, Joy A Pai, Yingying Cao, et al.
Cancer Discovery|December 23, 2024
Temporal genomic analysis of homogeneous tumor models reveals key regulators of immune evasion in melanomaSapir Cohen Shvefel, Joy A Pai, Yingying Cao, et al.
Nature Immunology|September 23, 2022
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancerJuan Dubrot, Peter P Du, Sarah Kate Lane-Reticker, et al.
Immunity|November 19, 2024
Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpointHsiao-Wei Tsao, Seth Anderson, Kenneth J Finn, et al.
Nature|January 12, 2023
Targeting TBK1 to overcome resistance to cancer immunotherapyYi Sun, Or-Yam Revach, Seth Anderson, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancer Discovery|January 28, 2025
Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in MelanomaSapir Cohen Shvefel, Joy A Pai, Yingying Cao, et al.
Cancer Discovery|December 23, 2024
Temporal genomic analysis of homogeneous tumor models reveals key regulators of immune evasion in melanomaSapir Cohen Shvefel, Joy A Pai, Yingying Cao, et al.
Nature Immunology|September 23, 2022
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancerJuan Dubrot, Peter P Du, Sarah Kate Lane-Reticker, et al.
Immunity|November 19, 2024
Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpointHsiao-Wei Tsao, Seth Anderson, Kenneth J Finn, et al.
Nature|January 12, 2023
Targeting TBK1 to overcome resistance to cancer immunotherapyYi Sun, Or-Yam Revach, Seth Anderson, et al.
Pageof 2